$1.740
-0.067 (-3.87%)Zum Schluss
- High
- 1.820
- Open
- 1.810
- VWAP
- 1.73
- Vol
- 285.52K
- Mkt Cap
- 49.43M
- Low
- 1.620
- Amount
- 493.00K
- EV/EBITDA, TTM
- 0.00
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Bewertungskennzahlen
Event-Zeitleiste
News
8.511-20GlobenewswireXOMA Royalty Completes Acquisition of LAVA Therapeutics N.V.
8.511-13NewsfilterLAVA Reports Surpassing Minimum Requirement in Tender Offer and Plans to Withdraw from Nasdaq
7.010-20PRnewswireShareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement
8.510-17GlobenewswireXOMA Royalty and LAVA Therapeutics Reveal Changes to Purchase Agreement
- 8.510-02Newsfilter
XOMA Royalty Prolongs Tender Offer to Purchase LAVA Therapeutics N.V.
LVTX FAQ — answered by Alphio AI
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer. It operates in the Healthcare sector.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.